title: Further evaluation of one-point microcapsule agglutination test for diagnosis of leptospirosis.
abstract: A total of 100 serum samples including 22 acute phase sera and 39 paired sera collected from clinically diagnosed cases of leptospirosis in Ming-shan County, Sichuan Province, China were examined by the one-point microcapsule agglutination test (MCAT), which was developed in Japan, and by conventional microscopic agglutination tests (MAT). The one-point MCAT is more reactive to IgM antibody than MAT and is superior in detecting antibodies in the early stages of the disease.
authors.affiliation: Chengdou Institute of Biological Products, China.
authors.forename: J J
authors.initials: JJ
authors.lastname: Cui
authors.forename: G X
authors.initials: GX
authors.lastname: Xiao
authors.forename: T Z
authors.initials: TZ
authors.lastname: Chen
authors.forename: G F
authors.initials: GF
authors.lastname: Zhu
authors.forename: T
authors.initials: T
authors.lastname: Sato
authors.forename: M
authors.initials: M
authors.lastname: Seki
authors.forename: S
authors.initials: S
authors.lastname: Kobayashi
authors.forename: Y
authors.initials: Y
authors.lastname: Arimitsu
mesh_terms: D000208:Acute Disease; D000372:Agglutination Tests / Q000379:methods*; D000907:Antibodies, Bacterial / Q000097:blood*; D002908:Chronic Disease; D006801:Humans; D007919:Leptospira / Q000276:immunology*; D007922:Leptospirosis / Q000175:diagnosis*; D011933:Reagent Kits, Diagnostic
chemical_list: D000907:Antibodies, Bacterial; D011933:Reagent Kits, Diagnostic